Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Resolve Growth Partners on the deal. Resolve Growth Partners announced the formation of its inaugural funds, Resolve Growth...
Resolve Growth Partners’ Fundraising
Resolve Growth Partners’ Fundraising
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Resolve Growth Partners on the deal. Resolve Growth Partners announced the formation of its inaugural funds, Resolve Growth...
Semrush’s $140 Million IPO
Goodwin Procter LLP advised Semrush on the deal. Semrush Holdings, Inc. (“Semrush”), a leading online visibility management SaaS platform, announced the closing of its initial public offering...
AbSci’s $125 Million Crossover Financing
Goodwin Procter LLP advised AbSci on the deal. AbSci, a pioneering synthetic biology company that unifies biologic drug discovery and development processes, announced a $125 million crossover financing. The...
Aura Biosciences’ $80 Million Financing Round
Goodwin Procter LLP advised Aura Biosciences on the deal. Aura Biosciences announced the closing of its oversubscribed $80 million financing. The financing was led by Matrix Capital...
Great Hill Partners’ $150 Million Investment in Jumio
Goodwin Procter LLP advised Great Hill Partners, while Winston & Strawn represented Jumio on the deal. Jumio, the leading provider of AI-powered end-to-end identity verification and...
Personalized Media Communications, LLC v. Apple, Inc.
Goodwin Procter LLP advised Personalized Media Communications on the deal. Personalized Media Communications (PMC) achieved a total victory in a patent infringement case against Apple, Inc.: Personalized Media Communications,...
Rubius Therapeutics’ $200 Million Underwritten Public Offering
Goodwin Procter LLP advised Rubius Therapeutics on the deal. Rubius Therapeutics (NASDAQ: RUBY) announced the upsized underwritten public offering of 6,896,552 shares of its common stock at...
TA Associates’ $2 Billion Acquisition of Unit4
Goodwin Procter LLP advised the management team of Unit4 on the deal, Kirkland & Ellis advised TA Associates. Unit4, an enterprise software company principally owned by...
Vaccitech’s $168 Million Series B Financing Round
Goodwin Procter LLP advised Vaccitech on the deal. Vaccitech announced the completion of its $168 million Series B, including the conversion of $43 million in convertible loan...
Everbridge, Inc.’s $375 Million Notes Offering
Goodwin Procter LLP advised the initial purchasers on the deal. Everbridge, Inc. (“Everbridge”) issued an aggregate of $375 million principal amount of its 0% Convertible Senior Notes...
Kosy Software Ltd’s Seed Financing Round
Goodwin Procter LLP advised Kosy Software Ltd on the deal. Kosy Software Ltd announced its seed financing round led by Picus Capital GmbH. Kosy is an...